跳至主要内容
临床试验/CTIS2023-508413-16-00
CTIS2023-508413-16-00进行中(未招募)1 期

OXYTAHANE - Oxygen therapy: Acute Treatment for paroxysmal dystonic or plegic attacks in alternating hemiplegia of childhood - APHP230673

Assistance Publique Hopitaux De Paris0 个研究点目标入组 24 人开始时间: 2023年12月21日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 至 65+(—)
性别
All

入选标准

  • 1.Age > 1 year old 2.Patients able to administrate high-flow oxygen through a non rebreathing facial mask, either alone or with assistance 3.Patients with a diagnosis of AHC caused by ATP1A3 mutations presenting at least one dystonic or plegic attack per week lasting more than 30 minutes 4.Absence of long-term treatment or long-term treatment stable over the last month and during the duration of the trial 5.Patients able to give written informed consent 6.Affiliation to social insurance

排除标准

  • 1.Inability for the patients and/or caregivers to follow the protocol (inability to read or understand the instructions, no access to smartphone or computer to fill the informatics patient’s form) 2.Patients with severe or uncontrolled obstructive or restrictive chronic respiratory disease (asthma, COPD, obesity, neuromuscular disease), acute systemic aggression (acute coronary syndrome, stroke, sepsis, head trauma) or congenital cardiopathy with a risk of hypercapnia following oxygen administration 3.Women that are pregnant (a negative pregnancy test is required for inclusion) or breath feeding 4.Patients involved in an other clinical trial

研究者

相似试验